Bicycle Therapeutics (BCYC) EBT (2018 - 2026)
Bicycle Therapeutics (BCYC) posted EBT of -$60.7 million for Q1 2026, down 129.36% on a QoQ basis from $206.6 million in Q4 2025, and up 1.92% year-over-year from -$59.5 million in Q1 2025.
Bicycle Therapeutics (BCYC) EBT (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' EBT history runs 9 years deep, the most recent figure standing at -$60.7 million for Q1 2026.
- Quarterly EBT rose 1.92% year-over-year to -$60.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 103.75% YoY) and the FY2025 annual result came in at $6.6 million, up 103.83% from the prior year.
- EBT was -$60.7 million for Q1 2026 at Bicycle Therapeutics, down from $206.6 million in the prior quarter.
- Across five years, EBT topped out at $206.6 million in Q4 2025 and bottomed at -$79.2 million in Q2 2025.
- A 5-year average of -$20.0 million and a median of -$39.7 million in 2024 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT surged 513.79% — and 2024, when it plunged 139.45%.
- Bicycle Therapeutics' EBT stood at -$32.4 million in 2022, then jumped by 513.79% to $134.2 million in 2023, then plunged by 139.45% to -$52.9 million in 2024, then surged by 490.22% to $206.6 million in 2025, then slumped by 129.36% to -$60.7 million in 2026.
- Business Quant data shows BCYC's EBT at -$60.7 million in Q1 2026, $206.6 million in Q4 2025, and -$58.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Bicycle Therapeutics | 272.11 Mn | 272.11 Mn | - | -60.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.65 Mn |
| Dec 31, 2025 | 206.57 Mn |
| Sep 30, 2025 | -58.90 Mn |
| Jun 30, 2025 | -79.18 Mn |
| Mar 31, 2025 | -61.84 Mn |
| Dec 31, 2024 | -52.94 Mn |
| Sep 30, 2024 | -54.25 Mn |
| Jun 30, 2024 | -39.70 Mn |
| Mar 31, 2024 | -26.91 Mn |
| Dec 31, 2023 | 134.20 Mn |
| Sep 30, 2023 | -47.63 Mn |
| Jun 30, 2023 | -43.12 Mn |
| Mar 31, 2023 | -39.68 Mn |
| Dec 31, 2022 | -32.43 Mn |
| Sep 30, 2022 | -28.59 Mn |
| Jun 30, 2022 | -27.28 Mn |
| Mar 31, 2022 | -27.98 Mn |
| Dec 31, 2021 | -18.79 Mn |
| Sep 30, 2021 | -15.09 Mn |
| Jun 30, 2021 | -18.07 Mn |